3[3]Schoenhagen P,Ziada KM,Vince DG,Nissen SE,Tuzcu EM.Arterial remodeling and coronary artery disease:the concept of "dilated" versus "obstructive" coronary atherosclerosis.J Am Coll Cardiol,2001,38:297-306.
4[4]Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:a randomized controlled trial.JAMA,2004,291:1071-1080.
5[5]Mazzone T,Meyer PM,Feinstein SB,et al.Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes:a randomized trial.JAMA,2006,296:2572-2581.
6[6]Nicholls SJ,Sipahi I,Colagiovanni A,et al.Arterial wall remodeling in response to atheroma regression with very intensive lipid lowering:insights from the ASTEROID trial.Circulation,2006,114:II-808.
7[7]Nicholls SJ,Sipahi I,Andrews J,et al.Proatherogenic impact of the ACAT inhibitor pactimibe in patients with coronary artery disease and multiple risk factors:insights from the ACTIVATE study.Circulation,2006,114:II-224.
8[8]Sipahi I,Tuzcu EM,Nicholls S J,et al.Effect of obesity on progression of coronary atherosclerosis:observations from four intravascular ultrasound trials.Circulation,2006,114:II-886.
9[9]Sipahi I,Tuzcu EM,Wolski KE,et al.Beta-blockers and progression of coronary atherosclerosis:a meta-analysis from four intravascular ultrasound trials.Circulation,2006,114:II-796.
10[10]Sipahi I,Tuzcu EM,Nicholls SJ,et al.Progression of coronary atherosclerosis:do ACE inhibitors make a difference Circulation,2006,114:II-796.
